Study of stem cells for the treatment of skin cancer

Research Article
Open access

Study of stem cells for the treatment of skin cancer

Dahui Liu 1*
  • 1 Stanstead College    
  • *corresponding author allenldh@outlook.com
Published on 20 December 2023 | https://doi.org/10.54254/2753-8818/23/20231066
TNS Vol.23
ISSN (Print): 2753-8826
ISSN (Online): 2753-8818
ISBN (Print): 978-1-83558-219-0
ISBN (Online): 978-1-83558-220-6

Abstract

As no medical treatments have been found to have made any valid impacts on curing cancer yet, immunotherapy, as an epoch-making medical treatment, has been said to have the potential to cure cancer. This review paper includes trials done by the American Joint Committee on Cancer (AJCC), and clinical trials of Avelumab as means to prove the significance of stem cells and immunotherapy in treating skin cancer. According to the research, a lower disease progression was noticed. This has shown the world that the development of medicine and medical care has stepped forward and an approaching success in curing cancer in the near future.

Keywords:

immunotherapy, skin cancer, stem cells, nonmelanoma skin cancer (NMSC)

Liu,D. (2023). Study of stem cells for the treatment of skin cancer. Theoretical and Natural Science,23,224-229.
Export citation

References

[1]. Brandt, M. W., & Moore, C. L. (2019). Nonmelanoma Skin Cancer. Facial Plastic Surgery Clinics of North America, 27(1), 1–13. https://doi.org/10.1016/j.fsc.2018.08.001

[2]. Zhang, Y., & Zhang, Z. (2020). The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cellular & Molecular Immunology, 17(8), 807–821. https://doi.org/10.1038/ s41423-020-0488-6

[3]. Ebrahimi, A., Ahmadi, H., Pourfraidon Ghasrodashti, Z., Tanide, N., Shahriarirad, R., Erfani, A., Ranjbar, K., & Ashkani-Esfahani, S. (2021, December 1). Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review. Bosnian journal of basic medical sciences. Retrieved November 28, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554700/

[4]. Guy, G. P., Thomas, C. C., Thompson, T., Watson, M., Massetti, G. M., & Richardson, L. C. (2015, June). Vital signs: Melanoma incidence and mortality trends and projections - United States, 1982-2030. MMWR. Morbidity and mortality weekly report. Retrieved December 18, 2022, from https://pubmed.ncbi.nlm.nih.gov/26042651/

[5]. Palmeri, M., Mehnert, J., Silk, A. W., Jabbour, S. K., Ganesan, S., Popli, P., Riedlinger, G., Stephenson, R., de Meritens, A. B., Leiser, A., Mayer, T., Chan, N., Spencer, K., Girda, E., Malhotra, J., Chan, T., Subbiah, V., & Groisberg, R. (2022, February). Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO open. Retrieved December 2, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717431/

[6]. Shalhout, S. Z., Emerick, K. S., Kaufman, H. L., & Miller, D. M. (2021, August). Immunotherapy for non-melanoma skin cancer. Current oncology reports. Retrieved February 13, 2023, from https://pubmed.ncbi.nlm.nih.gov/34448958/

[7]. Silk, A. W., Barker, C. A., Bhatia, S., Bollin, K. B., Chandra, S., Eroglu, Z., Gastman, B. R., Kendra, K. L., Kluger, H., Lipson, E. J., Madden, K., Miller, D. M., Nghiem, P., Pavlick, A. C., Puzanov, I., Rabinowits, G., Ruiz, E. S., Sondak, V. K., Tavss, E. A., … Brownell, I. (2022, July). Society for immunotherapy of cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. Journal for immunotherapy of cancer. Retrieved December 18, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC9341183/#

Cite this article

Liu,D. (2023). Study of stem cells for the treatment of skin cancer. Theoretical and Natural Science,23,224-229.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 3rd International Conference on Biological Engineering and Medical Science

ISBN：978-1-83558-219-0(Print) / 978-1-83558-220-6(Online)
Editor：Alan Wang
Conference website: https://www.icbiomed.org/
Conference date: 2 September 2023
Series: Theoretical and Natural Science
Volume number: Vol.23
ISSN：2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).

References

[1]. Brandt, M. W., & Moore, C. L. (2019). Nonmelanoma Skin Cancer. Facial Plastic Surgery Clinics of North America, 27(1), 1–13. https://doi.org/10.1016/j.fsc.2018.08.001

[2]. Zhang, Y., & Zhang, Z. (2020). The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cellular & Molecular Immunology, 17(8), 807–821. https://doi.org/10.1038/ s41423-020-0488-6

[3]. Ebrahimi, A., Ahmadi, H., Pourfraidon Ghasrodashti, Z., Tanide, N., Shahriarirad, R., Erfani, A., Ranjbar, K., & Ashkani-Esfahani, S. (2021, December 1). Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review. Bosnian journal of basic medical sciences. Retrieved November 28, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554700/

[4]. Guy, G. P., Thomas, C. C., Thompson, T., Watson, M., Massetti, G. M., & Richardson, L. C. (2015, June). Vital signs: Melanoma incidence and mortality trends and projections - United States, 1982-2030. MMWR. Morbidity and mortality weekly report. Retrieved December 18, 2022, from https://pubmed.ncbi.nlm.nih.gov/26042651/

[5]. Palmeri, M., Mehnert, J., Silk, A. W., Jabbour, S. K., Ganesan, S., Popli, P., Riedlinger, G., Stephenson, R., de Meritens, A. B., Leiser, A., Mayer, T., Chan, N., Spencer, K., Girda, E., Malhotra, J., Chan, T., Subbiah, V., & Groisberg, R. (2022, February). Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO open. Retrieved December 2, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717431/

[6]. Shalhout, S. Z., Emerick, K. S., Kaufman, H. L., & Miller, D. M. (2021, August). Immunotherapy for non-melanoma skin cancer. Current oncology reports. Retrieved February 13, 2023, from https://pubmed.ncbi.nlm.nih.gov/34448958/

[7]. Silk, A. W., Barker, C. A., Bhatia, S., Bollin, K. B., Chandra, S., Eroglu, Z., Gastman, B. R., Kendra, K. L., Kluger, H., Lipson, E. J., Madden, K., Miller, D. M., Nghiem, P., Pavlick, A. C., Puzanov, I., Rabinowits, G., Ruiz, E. S., Sondak, V. K., Tavss, E. A., … Brownell, I. (2022, July). Society for immunotherapy of cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. Journal for immunotherapy of cancer. Retrieved December 18, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC9341183/#

For authors
Guide for authors Policies for authors Aims and scope Subscription Open access policy
For editors
Policies for editors Editorial board
For reviewers
Policies for reviewers Privacy policy

Cookies are used by this site.
Copyright © 2024 EWA Publishing, its licensors, and contributors. All rights reserved, including text and data mining, AI training, and similar technologies.